CD8A and neoplasm: Responsiveness to AIT correlates to the ability of culture-expanded TIL to produce interferon- γ (IFNγ) upon tumor reexposure, as well as to the dual presence of CD4+ and CD8+ T-cells in the administered AIT product [5–7].